Procaps Group, S.A Price to Sales Ratio 2020-2023 | PROCF
Historical PS ratio values for Procaps Group, S.A (PROCF) over the last 10 years. The current P/S ratio for Procaps Group, S.A as of February 07, 2025 is .
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Procaps Group, S.A P/S Ratio Historical Data |
Date |
Stock Price |
TTM Sales per Share |
Price to Sales Ratio |
2025-02-03 |
1.01 |
|
0.25 |
2023-09-30 |
3.62 |
$4.10 |
0.88 |
2023-03-31 |
4.51 |
$4.04 |
1.12 |
2022-12-31 |
5.25 |
$4.05 |
1.29 |
2022-09-30 |
7.00 |
$4.34 |
1.61 |
2022-06-30 |
9.32 |
$4.35 |
2.14 |
2022-03-31 |
8.50 |
$4.32 |
1.97 |
2021-12-31 |
9.75 |
$4.50 |
2.17 |
2021-09-30 |
10.20 |
$4.00 |
2.55 |
2023-06-30 |
4.30 |
$53.34 |
0.08 |
2021-06-30 |
10.09 |
$52.25 |
0.19 |
2021-03-31 |
10.05 |
$51.23 |
0.20 |
2020-12-31 |
10.40 |
$50.43 |
0.21 |
2020-09-30 |
9.93 |
0 |
0.00 |
Sector |
Industry |
Market Cap |
Revenue |
Medical |
MED-DRUGS |
$0.125B |
$0.410B |
Procaps Group is a developer of pharmaceutical and nutraceutical solutions, medicines and hospital supplies. It develops, manufactures and markets over-the-counter and prescription drugs, nutritional supplements and high-potency clinical solutions. Procaps Group, formerly known as Union Acquisition Corp. II, is based in BARRANQUILLA, Colombia.
|